EUVIMEDEUVIMED entdecken
Crossref

Integrated Bioinformatics and Machine Learning Analysis Identifies MT1F as a Potential Diagnostic Biomarker and Therapeutic Target in Breast Cancer

Tahmid Islam Akib, Ibrahim Hossain Molla, Nafees Rishad, Labib Rahman, Nishad Al Hasan, Sidratul Muntaha Tasmi, Md Mahfujar Rahman Shakil, Ariful Islam

Atlantic Journal of Life Sciences · 2026

DOI: 10.71005/458kdy25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Atlantic Journal of Life Sciences, 2026. Verfasst von Tahmid Islam Akib und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BRCA) is a heterogeneous tumour and is the most common cancer in the world, and there is a need for strong biomarkers to enhance diagnosis and targeted therapy. We created a combined bioinformatics and machine learning approach for identifying important molecular biomarkers related to BRCA in this study. Two gene expression datasets were analyzed and 2,386 commonly dysregulated genes were identified. Enrichment analysis of functions indicated that extracellular matrix organization and immune related pathways were significantly involved. Protein protein interaction (PPI) network analysis revealed that MT1F and CCNA2 were hub genes in the network, and MT1F was consistently ranked among the most central genes by various topological and machine learning techniques. The machine learning models (Random Forest, Gradient Boosting, and XGBoost) showed high diagnostic performance, with the Random Forest model having the highest discriminative ability (AUC = 0.990). It was found that MT1F was significantly upregulated in many different malignancies by pan-cancer analysis and was epigenetically regulated by DNA methylation analysis. Immune infiltration analysis also showed significant correlations between the expression of MT1F and immune cell populations. The drug sensitivity analysis (DSA) with GSCA datasets showed that MT1F expression was significantly correlated with sensitivity to several anti cancer drugs, suggesting its role as a potential predictive biomarker. To conclude, MT1F might be a diagnostic biomarker and therapeutic target for breast cancer. This study highlights the value of integrative computational methods in the discovery of biomarkers and precision oncology.

Zitieren

APA

Akib, T. I., Molla, I. H., Rishad, N., Rahman, L., Hasan, N. A., Tasmi, S. M., Shakil, M. M. R., & Islam, A. (2026). Integrated Bioinformatics and Machine Learning Analysis Identifies MT1F as a Potential Diagnostic Biomarker and Therapeutic Target in Breast Cancer. Atlantic Journal of Life Sciences. https://doi.org/10.71005/458kdy25

Vancouver

Akib TI, Molla IH, Rishad N, Rahman L, Hasan NA, Tasmi SM, et al. Integrated Bioinformatics and Machine Learning Analysis Identifies MT1F as a Potential Diagnostic Biomarker and Therapeutic Target in Breast Cancer. Atlantic Journal of Life Sciences. 2026. doi:10.71005/458kdy25

BibTeX
@article{Akib2026,
  author = {Akib, Tahmid Islam and Molla, Ibrahim Hossain and Rishad, Nafees and Rahman, Labib and Hasan, Nishad Al and Tasmi, Sidratul Muntaha and Shakil, Md Mahfujar Rahman and Islam, Ariful},
  title = {Integrated Bioinformatics and Machine Learning Analysis Identifies MT1F as a Potential Diagnostic Biomarker and Therapeutic Target in Breast Cancer},
  journal = {Atlantic Journal of Life Sciences},
  year = {2026},
  doi = {10.71005/458kdy25}
}
Kostenlos starten →